Evidence map›Paper›PMID 32546243›Full record

ArticleActa veterinaria Scandinavica2020

Determination of anticoagulant rodenticides in faeces of exposed dogs and in a healthy dog population.

Kristin Opdal Seljetun, Vigdis Vindenes, Elisabeth Leere Øiestad, Gerd-Wenche Brochmann, Elin Eliassen, Lars Moe

Open access · goldAbstract read
In one paragraph

Article in Acta veterinaria Scandinavica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Diagnosis and successful management of an extradural compressive hematoma secondary to diphacinone poisoning in a dog.Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) · 2023
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kristin Opdal SeljetunDepartment of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences (NMBU), P. O. Box 369, Sentrum, 0102, Oslo, Norway. kristin.opdal.seljetun@nmbu.no.ORCID http://orcid.org/0000-0001-9921-2692
Vigdis VindenesDepartment of Forensic Sciences, Division of Laboratory Medicine, Oslo University Hospital, P. O. Box 4450, Nydalen, 0424, Oslo, Norway.
Elisabeth Leere ØiestadSchool of Pharmacy, University of Oslo, P. O. Box 1068, Blindern, 0316, Oslo, Norway.
Gerd-Wenche BrochmannDepartment of Forensic Sciences, Division of Laboratory Medicine, Oslo University Hospital, P. O. Box 4450, Nydalen, 0424, Oslo, Norway.
Elin EliassenDepartment of Forensic Sciences, Division of Laboratory Medicine, Oslo University Hospital, P. O. Box 4450, Nydalen, 0424, Oslo, Norway.
Lars MoeDepartment of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences (NMBU), P. O. Box 369, Sentrum, 0102, Oslo, Norway.
Oslo University Hospital · NONorwegian Institute of Public Health · NONorwegian University of Life Sciences · NOUniversity of Oslo · NO

Funding

Agria Djurförsäkring (SE) N2017-011
6 · The paper itself

Abstract

backgroundExposure to anticoagulant rodenticides (ARs) in dogs is among the most common causes of poisoning in small animal practice, but information about toxicokinetic of these rodenticides in dogs is lacking. We analysed blood and faeces from five accidentally exposed dogs and 110 healthy dogs by reversed phase ultra-high performance liquid chromatography-tandem mass spectrometry. The aim of the study was to estimate elimination of brodifacoum, bromadiolone and difenacoum after acute exposure, calculate the half-lives of these rodenticides in dogs, estimate faecal elimination in a litter of puppies born, and further to identify the extent of AR exposure in a healthy dog population.

resultsThree dogs were included after single ingestions of brodifacoum; two dogs ingested bromadiolone and one dog ingested difenacoum. Maximum concentrations in faeces were found after day 2-3 for all ARs. The distribution half-lives were 1-10 days for brodifacoum, 1-2 days for bromadiolone and 10 days for difenacoum. Brodifacoum and difenacoum had estimated terminal half-lives of 200-330 days and 190 days, respectively. In contrast, bromadiolone had an estimated terminal half-life of 30 days. No clinical signs of poisoning or coagulopathy were observed in terminal elimination period. In blood, the terminal half-life of brodifacoum was estimated to 8 days. Faeces from a litter of puppies born from one of the poisoned dogs were examined, and measurable concentrations of brodifacoum were detected in all samples for at least 28 days after parturition. A cross-sectional study of 110 healthy domestic dogs was performed to estimate ARs exposure in a dog population. Difenacoum was detected in faeces of one dog. Blood and faecal samples from the remaining dogs were negative for all ARs.

conclusionsBased on the limited pharmacokinetic data from these dogs, our results suggest that ARs have a biphasic elimination in faeces using a two-compartment elimination kinetics model. We have shown that faecal analysis is suitable and reliable for the assessment of ARs exposure in dogs and a tool for estimating the AR half-lives. Half-lives of ARs could be a valuable indicator in the exposed dogs and provides important information for veterinarians monitoring AR exposure and assessment of treatment length in dogs.

Indexed as

4-HydroxycoumarinsAnimalsAnticoagulantsChromatography, High Pressure LiquidDogsFecesMass SpectrometryRodenticides4-HydroxycoumarinsAnticoagulantsbromadiolonebromfenacoumdifenacoumRodenticidesBrodifacoumBromadioloneCanineDifenacoumIntoxicationNon-target animalRodenticide

Identifiers

PMID32546243
PMCPMC7296905
OpenAlexW3034314801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.